| Product Name | Orteronel - API |
| Product Code | DA-O111-a |
| Chemical name | Orteronel |
| Synonyms | (S)-6-(7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide; 2-Naphthalenecarboxamide, 6-[(7S)-6,7-dihydro-7-hydroxy-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl; 6-[(7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide; |
| Impurity | NA |
| CAS Number | 566939-85-3 |
| Alternate CAS # | NA |
| Molecular form | C18H17N3O2 |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 307.35 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | pharmaceutical standards,Fine Chemicals,metabolites,impurities,enzyme activators,enzyme inhibitors |
| Boiling Point | NA |
| Applications | Orteronel is an androgen synthesis inhibitor that selectively inhibits enzyme CYP17A1, which is expressed in testicular, adrenal and prostatic tumor tissues. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
